MicroRNA-137 (miR-137) is down-regulated in pancreatic cancer and promotes anoikis by modulating the AKT signaling pathway, with paxillin (PXN) identified as a target of miR-137 that promotes AKT activation [252]. The gene discussed is PXN; the disease is pancreatic neoplasm.